Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001181431-13-004491

Options or other derivatives

  • Director acquired 6,260 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

CHAPLIN DAVID · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2013-01-23 Grant or award : show line 1 in the form Stock Option (Right to Buy) +6,260 6,260 D
Loading xslF345X03/rrd366939.xml…